Conserved requirement of autophagy-related effectors during coronavirus replication

Autophagy. 2023 Feb;19(2):731-733. doi: 10.1080/15548627.2022.2100617. Epub 2022 Jul 24.

Abstract

The recurrence of zoonotic transmission events highlights the need for novel treatment strategies against emerging coronaviruses (CoVs), namely SARS-CoV, MERS-CoV and most notably SARS-CoV-2. Our recently performed genome-wide CRISPR knockout screen revealed a list of conserved pan-coronavirus as well as MERS-CoV or HCoV-229E-specific host dependency factors (HDF) essential during the viral life cycle. Intriguingly, we identified the macroautophagy/autophagy pathway-regulating immunophilins FKBP8, TMEM41B, and MINAR1 as conserved MERS-CoV, HCoV-229E, SARS-CoV, and SARS-CoV-2 host factors, which further constitute potential targets for therapeutic intervention by clinically approved drugs.

Keywords: Antiviral target; CRISPR screen; autophagy; coronavirus; host factor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autophagy*
  • COVID-19
  • Coronavirus 229E, Human
  • Host-Derived Cellular Factors*
  • Humans
  • Immunophilins*
  • Middle East Respiratory Syndrome Coronavirus
  • SARS-CoV-2
  • Severe acute respiratory syndrome-related coronavirus
  • Virus Replication*

Substances

  • Immunophilins
  • Host-Derived Cellular Factors